Загрузка...
Cost-effectiveness of lipid lowering with statins and ezetimibe in chronic kidney disease
Statin-based treatments reduce cardiovascular disease (CVD) risk in patients with non-dialysis chronic kidney disease (CKD), but it is unclear which regimen is the most cost-effective. We used the Study of Heart and Renal Protection (SHARP) CKD-CVD policy model to evaluate the effect of statins and...
Сохранить в:
| Опубликовано в: : | Kidney Int |
|---|---|
| Главные авторы: | , , , , , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Elsevier
2019
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6595178/ https://ncbi.nlm.nih.gov/pubmed/31005271 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.kint.2019.01.028 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|